Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): a randomised, double-blind, placebo-controlled, phase 3 trial

Published:2017-11 Issue:11 Volume:4 Page:e534-e543
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Chanan-Khan Asher A,Zaritskey Andrey,Egyed Miklos,Vokurka Samuel,Semochkin Sergey,Schuh Anna,Kassis Jeannine,Simpson David,Zhang Jennie,Purse Brendan,Foà Robin

Publisher

Elsevier BV

Subject

Hematology

Reference39 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2015

3. NCCN Clinical Practice Guidelines in Oncology: chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2017,2016

4. Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia;Rossi;Blood,2015

5. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial;Fischer;Blood,2016

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance therapy for chronic lymphocytic leukaemia;Cochrane Database of Systematic Reviews;2024-01-04

2. Treatment of Chronic Lymphocytic Leukemia in the Personalized Medicine Era;Pharmaceutics;2023-12-29

3. Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis;The Lancet Haematology;2022-12

4. Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis;Frontiers in Pharmacology;2022-09-14

5. Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling;Cell Chemical Biology;2022-08